On April 8, the world's first LbGp production line was officially put into operation in Zhongning county new aquatic agricultural products processing and entrepreneurship Park, further extending the development chain of Zhongning Lycium barbarum industry and increasing the added value of Lycium barbarum products.

ZhongningLycium barbarum has a planting area of 200000 mu. In recent years, it has gradually realized the batch production of Lycium barbarum fruit wine,Lycium barbarum seed oil and other deeply processed products, but it is still in the low-level form transformation of "fromLycium barbarum toLycium barbarum". With the scientific research support of Shanghai Institute of organic chemistry, Chinese Academy of Sciences, Ningxia Tianren Goji Biotechnology isolatedLycium barbarum glycopeptide that can improve human immunity from ZhongningLycium barbarum, and realized the mass production ofLycium barbarum glycopeptide buccal tablets.

It is understood that Ningxia Tianren Goji Biotechnology plans to invest 450 million yuan to build a production base of medlar glycopeptide series products with an annual output of 20 tons in three phases. At present, the first phase of the project has been completed, with an annual production capacity of 5 tons, a consumption of 500 tons of Zhongning medlar dry fruit, an annual output value of 1 billion yuan and an annual profit and tax of 200 million yuan.